GB201820529D0 - Compounds and combinations for the treatment of rosacea - Google Patents

Compounds and combinations for the treatment of rosacea

Info

Publication number
GB201820529D0
GB201820529D0 GBGB1820529.4A GB201820529A GB201820529D0 GB 201820529 D0 GB201820529 D0 GB 201820529D0 GB 201820529 A GB201820529 A GB 201820529A GB 201820529 D0 GB201820529 D0 GB 201820529D0
Authority
GB
United Kingdom
Prior art keywords
rosacea
combinations
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1820529.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMERITI PHARMA AB
Original Assignee
EMERITI PHARMA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMERITI PHARMA AB filed Critical EMERITI PHARMA AB
Priority to GBGB1820529.4A priority Critical patent/GB201820529D0/en
Publication of GB201820529D0 publication Critical patent/GB201820529D0/en
Ceased legal-status Critical Current

Links

GBGB1820529.4A 2018-12-17 2018-12-17 Compounds and combinations for the treatment of rosacea Ceased GB201820529D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1820529.4A GB201820529D0 (en) 2018-12-17 2018-12-17 Compounds and combinations for the treatment of rosacea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1820529.4A GB201820529D0 (en) 2018-12-17 2018-12-17 Compounds and combinations for the treatment of rosacea

Publications (1)

Publication Number Publication Date
GB201820529D0 true GB201820529D0 (en) 2019-01-30

Family

ID=65147158

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1820529.4A Ceased GB201820529D0 (en) 2018-12-17 2018-12-17 Compounds and combinations for the treatment of rosacea

Country Status (1)

Country Link
GB (1) GB201820529D0 (en)

Similar Documents

Publication Publication Date Title
IL276398A (en) Combination therapy for the treatment of mastocytosis
IL279260A (en) Kdm1a inhibitors for the treatment of disease
GB201804514D0 (en) Treatment of pyroptosis
PT3416957T (en) 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes
GB201820450D0 (en) Compound and its use for the treatment of alpha1-antitryspin deficiency
GB201813876D0 (en) Treatment
IL283948A (en) Methods for the treatment of depression
PT3416945T (en) 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
IL282007A (en) Medicament for the treatment of chronic cough
IL276482A (en) Compounds for the treatment of pain
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
GB201804515D0 (en) Treatment of necroptosis
GB201800546D0 (en) Treatment
PL3448340T3 (en) Application aid for the treatment of wounds
IL281839A (en) Treatment methods
IL281792A (en) Treatment methods
GB201916428D0 (en) Treatment of hydro-carbon-contaminated materials
IL282059A (en) Avexitide for the treatment of hyperinsulinemic hypoglycemia
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
PL3630754T3 (en) Isoindoline-acetylene compounds for the treatment of cancer
GB201820529D0 (en) Compounds and combinations for the treatment of rosacea
GB201721278D0 (en) Compunds and combinations for the treatment of rosacea
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)